Exparel 133 MG/10 ML vial 10ML

Ended Awarded

Contract number
SPE2DR26FDAH8
Awardee
Awarding agency
Obligated
$15,412

Award facts

Contract value 100% obligated
$15,411.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on June 8, 2026, for EXPAREL 133 mg/10 mL vials with a ceiling value of $15,411.50, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical is a woman-owned small business headquartered in Park Ridge, Illinois, and holds the single-award indefinite delivery contract (SPE2DX) under PPV-G GEN V with a $499.999 billion ceiling through December 31, 2036. Place of performance is Park Ridge, IL. The order is priced on a firm fixed-price basis with an ultimate completion date of June 30, 2026.

Quick answers

Who was awarded contract SPE2DR26FDAH8?

SPE2DR26FDAH8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 8, 2026.

How much is contract SPE2DR26FDAH8 worth?

The government has obligated $15,412 on SPE2DR26FDAH8.

Is contract SPE2DR26FDAH8 an order under another contract?

Yes. SPE2DR26FDAH8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.

Was contract SPE2DR26FDAH8 competed?

The extent of competition for SPE2DR26FDAH8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login